Related Experiment Video
Updated: Jun 8, 2026
05:58
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
Tumors on chips: oncology meets microfluidics
Donald Wlodkowic1, Jonathan M Cooper
1Auckland Microfabrication Facility, Department of Chemistry, University of Auckland, Auckland, New Zealand. d.wlodkowic@auckland.ac.nz
Current Opinion in Chemical Biology
|September 14, 2010
Summary
Microfluidic Lab-on-a-Chip (LOC) technology offers advanced 4D analysis for complex cancer research. This technology promises to accelerate drug discovery and improve cancer diagnostics by enabling high-throughput screening and detailed cellular studies.
Area of Science:
- Oncology
- Biotechnology
- Microfluidics
Background:
- Cancer remains a complex disease with low survival rates despite extensive research.
- Understanding molecular mechanisms and therapy resistance is vital for developing new anti-cancer strategies.
- Current research requires advanced tools for high-throughput, single-cell level analysis.
Purpose of the Study:
- To review emerging applications of microfluidic technologies in cancer biology and experimental oncology.
- To highlight the advantages of microfluidic systems for studying cancer complexity.
- To summarize recent advances in miniaturized systems for cancer research and drug development.
Main Methods:
- Discussion of microfluidic Lab-on-a-Chip (LOC) and micro-total analysis systems (microTAS).
- Review of miniaturized systems for studying cancer cell microenvironment and cancer cytomics.
- Summary of real-time (4D) pharmacological screening using microfabricated systems.
Main Results:
- Microfluidic technologies enable massive experimental parallelization and 4D analysis at the single-cell level.
- Miniaturized systems facilitate detailed studies of the cancer cell microenvironment and cytomics.
- On-chip technologies like cell microarrays, label-less cytometry, and micro-sorting show potential for drug screening.
Conclusions:
- Microfluidic technologies are promising platforms for addressing the complexity of cancer.
- These systems offer significant advantages for pharmacological screening, drug discovery, and clinical oncology.
- Microfluidic solutions are poised to become the preferred platform for next-generation in vitro cancer models.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...